MyAverix Finance
F · Healthcare
Aligos Therapeutics, Inc. (5WK0)
Biotechnology
Aligos Therapeutics, Inc. (5WK0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 5WK0
Aligos Therapeutics, Inc. (5WK0) — FAQ
What is 5WK0's P/E ratio?
The price-to-earnings (P/E) ratio for Aligos Therapeutics, Inc. (5WK0) is 18.00 (data as of 2026-03-24).
Does Aligos Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Aligos Therapeutics, Inc. (5WK0). Check the MyAverix Finance app for the latest dividend data.
What sector is Aligos Therapeutics, Inc. in?
Aligos Therapeutics, Inc. (5WK0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 5WK0 listed on?
5WK0 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.